Brighton Jones LLC
RCKT icon

Brighton Jones LLC’s Rocket Pharmaceuticals RCKT Stock Holding History

Brighton Jones LLC’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32.1K Sell
12,204
-20,783
-63% -$72K ﹤0.01% 1370
2026
Q2 		$113K Buy
32,987
+8,221
+33% +$27.3K ﹤0.01% 1303
2026
Q1 		$88.7K Buy
+24,766
New +$98.4K ﹤0.01% 1132

Other funds holding RCKT

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Brighton Jones LLC's RCKT Position: Q3 2026 in Review

Brighton Jones LLC reduced its Rocket Pharmaceuticals (RCKT) stake by 63% in Q3 2026, selling an estimated $72K and leaving 12,204 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

Brighton Jones LLC first reported a position in RCKT in Q1 2026 and has held it in 3 quarters since. The position peaked at $113K in Q2 2026. 94 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • Brighton Jones LLC held 12,204 shares of Rocket Pharmaceuticals worth $32.1K as of Q3 2026.
  • Brighton Jones LLC sold 20,783 Rocket Pharmaceuticals shares in Q3 2026, an estimated $72K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Brighton Jones LLC's portfolio in Q3 2026, its #1370 holding.
  • Brighton Jones LLC first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Brighton Jones LLC's Rocket Pharmaceuticals position peaked at $113K in Q2 2026.
  • 94 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on Brighton Jones LLC's 13F filing for Q3 2026, filed 3 Nov 2026.